Entering text into the input field will update the search result below

Celldex Therapeutics, Inc beats by $0.01, beats on revenue

  • Celldex Therapeutics, Inc (NASDAQ:CLDX): Q4 EPS of -$0.27 beats by $0.01.
  • Revenue of $0.6M (-83.6% Y/Y) beats by $0.33M.
  • Press Release

Recommended For You

More Trending News

About CLDX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CLDX--
Celldex Therapeutics, Inc.